Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL514182

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C=C1/C(=C\C=C2/CCC[C@]3(C)C(C4(CC#CC(C)(C)O)CC4)=CC[C@@H]23)C[C@@H](O)C[C@@H]1F

Basic Information

ChEMBL ID CHEMBL514182
Phase Preclinical
Structure Type MOL
InChI Key UBLQWMYKAJVRIQ-LMQQRSCXSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

424.6
MW (Da)
5.97
ALogP
2
HBA
2
HBD
40.5
PSA (Ų)
0.43
QED
1
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C28H37FO2
MW 424.60
Aromatic Rings 0
Heavy Atoms 31
NP-Likeness 1.80

Activity Summary

IC50 1 meas. best 10.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PBMC
CHEMBL613107
IC50 10.8 10.8 0.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PBMC IC50 = 0.016 nM 10.8 Inhibition of LPS-induced TNFalpha production in human PBMC after 24 hrs by ELIS... 19309155

Literature References

PubMed DOI Target Context # Activities
19309155 10.1021/jm801365a PBMC 2

Data from ChEMBL 36 via Core Engine